Description

Pentoxifillin-N (Pentoxifylline) 20 mg/ml. 5 ml. Ampoules №5

Ingredients:

Each 5 ml ampoule contains 20 mg of Pentoxifylline.

Dosage:

The usual dosage is 1 ampoule (5 ml) three times a day. Dosage may vary depending on the condition being treated. Consult a healthcare professional for personalized recommendations.

Indications:

Pentoxifillin-N is indicated for the treatment of peripheral vascular diseases. It helps improve blood flow by decreasing its viscosity, which can alleviate symptoms such as pain or cramping in the legs during exercise.

Contraindications:

Do not use Pentoxifillin-N if you have a history of bleeding disorders or recent hemorrhage. It is also contraindicated in patients with hypersensitivity to pentoxifylline or other methylxanthines.

Directions:

Administer Pentoxifillin-N as directed by a healthcare provider. It can be given orally or through intravenous infusion. Follow the instructions on the label or as prescribed.

Scientific Evidence:

Pentoxifylline, the active ingredient in Pentoxifillin-N, has been extensively studied for its effects on peripheral vascular diseases. Research published in the Journal of Vascular Surgery demonstrated that pentoxifylline can improve walking distance and reduce symptoms in patients with intermittent claudication.

Additional Information:

• Storage: Store Pentoxifillin-N at room temperature away from moisture and heat.
• Pregnancy and Lactation: Consult a healthcare professional before using Pentoxifillin-N during pregnancy or breastfeeding.

Pharmacological Effects: Pentoxifylline works by improving blood flow and increasing the flexibility of red blood cells, allowing them to pass more easily through narrowed blood vessels. This mechanism helps enhance oxygen delivery to tissues and reduce symptoms of peripheral vascular diseases.

Clinical Trials: Clinical trials have shown that Pentoxifylline can significantly improve symptoms and quality of life in patients with peripheral arterial disease. A study published in the European Journal of Vascular and Endovascular Surgery reported a reduction in pain and an increase in walking distance in patients treated with Pentoxifylline compared to a control group.